Elsevier Launches New Procedures Consult App for iPad, iPhone & iPod Touch

Optimized for quick, on-demand resource - including instructional videos - for medical professionals

Philadelphia, PA, December 5, 2011 -- Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that its new Procedures Consult App for iPad, iPhone and iPod Touch is now available on the App Store. The app allows for procedure videos, illustrations and text to be stored on a user's iOS device with customized user interfaces. Doctors can now work more confidently with whenever, wherever access to the critical and reliable content of Procedures Consult, including at the bedside.

The Procedures Consult App delivers a single resource of high quality videos for all procedures required by the American Board of Internal Medicine (ABIM), and conforms to the Accreditation Council for Graduate Medical Education (ACGME). It enables physicians, residents and medical students to more confidently perform these procedures, such as a subclavian line insertion or lumbar puncture, improving patient safety and helping to achieve the best patient outcomes.

“The Procedures Consults App is unmatched in its breadth of coverage and the quality of the videos it delivers, providing incredible value to physicians at the point of care,” said Randy Charles, Managing Director, Global Clinical Reference, Elsevier. “In addition to offering anytime and anywhere access to content, the Procedures Consult App also saves valuable time due to its mobile-friendly, easy-to-learn navigation, enabling better decision-making and ultimately moving critical content to the point of care.”

Unique features of the Procedures Consult App include:

The Procedures Consult App is available for free from the App Store on iPad, iPhone or iPod Touch or at  www.iTunes.com/appstore

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Tom Reller
Vice President Global Corporate Relations, Elsevier
+1 215 239 3508
t.reller@elsevier.com